Why not subscribe for full access to our resources?
Or, while you decide, why not sign up for free Membership?
Health systems continue to evolve while evidence expectations, assessment methods, and the roles of national bodies and cross-border collaborations develop with them. Access teams must handle the increase in complexity both on a national and international level.
How does the access professional keep up with these developments, and where do you go to check your understanding of a particular requirement? Posts on social media, conference presentations, HTA bodies’ newsletters? There are a lot of good news sources out there, but you have to be vigilant not to miss anything, and then do you understand the context?
LiSAH brings together a range of structured resources to keep you up to date and interpret developments in the context of current practice. We provide resources to help you carry out your role and support your growth as an access professional.
We have designed our service for access professionals working in Life Sciences product manufacturing and we focus on the pharmaceutical and allied sectors, including the biotechnology and advanced therapy medicinal segments.
We also recognise that there are many with a professional or personal interest in how medicines are made available for use by patients, for example:
Colleagues with other responsibilities in the Life Sciences sector such as in Health Economics and Outcomes Research (HEOR), Research and Development, Medical Affairs, Commercial or General Management;
Those who provide consultancy or other specialist services to the access function;
Those who represent patient organisations who want to understand how the medicines that their members depend on are approved for use in their healthcare system;
Employees of health authorities who are expert in their own system but who may want to check how another country addresses a particular aspect of the access process;
Academics who want a practical perspective on the access role to complement their research activity.
While there are aspects of our service such as health policy and health economics that we feel are of value to the medical technology sector, we recognise that we do not address the specifics of the access process for this segment. If you work in this sector and would like us to develop dedicated materials, please get in touch.
Click here for more information.
Click here for more information.
Please accept {{cookieConsents}} cookies to view this content